Literature DB >> 34097664

Estimated SARS-CoV-2 Seroprevalence in Healthy Children and Those with Chronic Illnesses in the Washington Metropolitan Area as of October 2020.

Burak Bahar1,2, Joelle N Simpson3, Cara Biddle4, Andrew Campbell5, Jeffrey S Dome6, Roberta L DeBiasi7,8, Catriona Mowbray6, Stefanie Marguilies5, Adrienne Sherman9,10, Jacqueline Reuben9, Meghan Delaney1,2.   

Abstract

The estimated severe acute respiratory syndrome coronavirus 2 seroprevalence in children was found to be 9.46% for the Washington Metropolitan area. Hispanic/Latinx individuals were found to have higher odds of seropositivity. While chronic medical conditions were not associated with having antibodies, previous fever and body aches were predictive symptoms.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID： 34097664     DOI： 10.1097/INF.0000000000003140

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  4 in total

Review 1.  [Seroprevalence of SARS-CoV-2 among children and adolescents in Germany-an overview].

Authors:  Roma Thamm; Nina Buttmann-Schweiger; Julia Fiebig; Christina Poethko-Müller; Franziska Prütz; Giselle Sarganas; Hannelore Neuhauser
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-11-03       Impact factor: 1.513

2.  SARS-CoV-2 infections in infants in Haiti 2020-2021; evidence from a seroepidemiological cohort.

Authors:  Rigan Louis; Ruiyu Pu; Tracey D Logan; Luke Trimmer-Smith; Richard Chamblain; Adriana Gallagher; Valery Madsen Beau De Rochars; Eric Nelson; Derek A T Cummings; Maureen T Long; J Glenn Morris
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

3.  Examining multi-level immune response to determine prevalence of COVID-19 in pediatric tonsillectomy.

Authors:  Pamela Mudd; Nahir Romero; Hengameh Behzadpour; Qin Xu; Md Sohel Rana; Lyuba Gitman; Diego Preciado; Maria Karkanitsa; Jacquelyn Spathies; Kaitlyn Sadtler; Heather Kalish; Pamela L Schwartzberg; Kalpana Manthiram
Journal:  Laryngoscope       Date:  2022-09-14       Impact factor: 2.970

4.  Missing science: A scoping study of COVID-19 epidemiological data in the United States.

Authors:  Rajiv Bhatia; Isabella Sledge; Stefan Baral
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.